An Alabama mother and father have filed a Zofran lawsuit against GlaxoSmithKline alleging the company’s anti-nausea medication caused their son’s congenital heart defect. The claims claims the mother used Zoran during her pregnancy to help with morning sickness. When the couple’s child was born in 2013, he was diagnosed with atrial septal defect, a severe birth complication that has required multiple surgeries.
Zofran, an antiemetic used to treat nausea and vomiting ...
continue reading...
The U.S. Judicial Panel on Multidistrict Litigation has moved to consolidate a dozen federal Zofran birth defect lawsuits in the U.S. District Court for the District of Massachusetts. In its October 13 transfer order, the Panel explained the decision to centralize in Massachusetts. Zofran maker GlaxoSmithKline had originally petitioned for the litigation to be held in the Eastern District of Pennsylvania, where the company is headquartered.
Although only 12 cases ...
continue reading...
A California mother has filed a Zofran birth defect lawsuit against GlaxoSmithKline claiming that the company’s antiemetic drug led her child to be born with a cleft lip and cleft palate. The new case joins dozens of similar Zofran lawsuits that both plaintiffs and GlaxoSmithKline are trying to have consolidated in a multidistrict litigation.
Zofran is approved by the U.S. Food and Drug Administration for ...
continue reading...
